Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 5:30 pm Sale | 2025-10-09 | 13D | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -11,668,473 (Position Closed) | Filing History |
| 2025-10-07 4:12 pm Sale | 2025-09-30 | 13G | ESSA Pharma Inc. EPIX | MORGAN STANLEY MS | 1,904,062 4.000% | -2,282,516 (-54.52%) | Filing History |
| 2025-08-07 4:31 pm Purchase | 2025-08-05 | 13D | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 11,668,473 24.700% | 2,919,844 (+33.37%) | Filing History |
| 2025-07-30 4:15 pm Unchanged | 2025-07-30 | 13G | ESSA Pharma Inc. EPIX | TANG CAPITAL MANAGEMENT, LLC | 4,300,000 9.700% | 0 (Unchanged) | Filing History |
| 2025-07-21 4:30 pm Purchase | 2025-07-17 | 13D | ESSA Pharma Inc. EPIX | Soleus Capital Master Fund, L.P. | 4,362,026 9.800% | 2,100,000 (+92.84%) | Filing History |
| 2025-04-24 08:56 am Unchanged | 2025-04-24 | 13D | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,221,546 9.500% | 0 (Unchanged) | Filing History |
| 2025-04-23 9:45 pm Unchanged | 2025-04-23 | 13D | ESSA Pharma Inc. EPIX | Soleus Capital Master Fund, L.P. | 2,262,026 5.100% | 0 (Unchanged) | Filing History |
| 2025-04-15 4:46 pm Purchase | 2025-04-15 | 13D | ESSA Pharma Inc. EPIX | Soleus Capital Master Fund, L.P. | 2,262,026 5.100% | 2,262,026 (New Position) | Filing History |
| 2025-04-09 09:00 am Unchanged | 2025-04-09 | 13D | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.700% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences, LP | 0 0.000% | -2,742,936 (Position Closed) | Filing History |
| 2025-02-14 10:26 am Purchase | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,221,546 9.500% | 38,323 (+0.92%) | Filing History |
| 2025-02-14 09:49 am Unchanged | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,183,223 9.400% | 0 (Unchanged) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 1,113,002 2.500% | -2,148,494 (-65.87%) | Filing History |
| 2025-02-11 4:00 pm Sale | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | Soleus Capital Special Opportunities Fund, L.P. | 2,262,026 5.100% | -2,065,596 (-47.73%) | Filing History |
| 2024-11-14 7:32 pm Sale | 2024-11-01 | 13G | ESSA Pharma Inc. EPIX | BB BIOTECH AG | 0 0.000% | -7,879,583 (Position Closed) | Filing History |
| 2024-11-14 4:04 pm Sale | 2024-09-30 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences, LP | 2,742,936 6.200% | -519,564 (-15.93%) | Filing History |
| 2024-11-14 06:56 am Purchase | 2024-09-30 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 3,261,496 7.400% | 962,834 (+41.89%) | Filing History |
| 2024-11-08 4:56 pm Purchase | 2024-11-01 | 13D | ESSA Pharma Inc. EPIX | TANG CAPITAL MANAGEMENT, LLC | 4,300,000 9.700% | 4,300,000 (New Position) | Filing History |
| 2024-11-07 12:50 pm Purchase | 2024-11-01 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,183,223 9.400% | 4,183,223 (New Position) | Filing History |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences, LP | 3,262,500 7.400% | -581,832 (-15.13%) | Filing History |